256 related articles for article (PubMed ID: 27678079)
1. The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis.
Varney JE; Liew D; Weiland TJ; Inder WJ; Jelinek GA
BMC Health Serv Res; 2016 Sep; 16(1):521. PubMed ID: 27678079
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of a telephone-linked care intervention for individuals with Type 2 diabetes.
Gordon LG; Bird D; Oldenburg B; Friedman RH; Russell AW; Scuffham PA
Diabetes Res Clin Pract; 2014 Apr; 104(1):103-11. PubMed ID: 24503043
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care.
Oksman E; Linna M; Hörhammer I; Lammintakanen J; Talja M
BMC Health Serv Res; 2017 Feb; 17(1):138. PubMed ID: 28202032
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a telephone-delivered intervention for physical activity and diet.
Graves N; Barnett AG; Halton KA; Veerman JL; Winkler E; Owen N; Reeves MM; Marshall A; Eakin E
PLoS One; 2009 Sep; 4(9):e7135. PubMed ID: 19779611
[TBL] [Abstract][Full Text] [Related]
5. Effect of hospital-based telephone coaching on glycaemic control and adherence to management guidelines in type 2 diabetes, a randomised controlled trial.
Varney JE; Weiland TJ; Inder WJ; Jelinek GA
Intern Med J; 2014 Sep; 44(9):890-7. PubMed ID: 24963611
[TBL] [Abstract][Full Text] [Related]
6. Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial.
O'Reilly DJ; Blackhouse G; Bowen JM; Brozic A; Agema P; Punthakee Z; McInnes N; Gerstein HC; Sherifali D
Can J Diabetes; 2022 Mar; 46(2):165-170. PubMed ID: 35115250
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management.
Grustam AS; Severens JL; De Massari D; Buyukkaramikli N; Koymans R; Vrijhoef HJM
Value Health; 2018 Jul; 21(7):772-782. PubMed ID: 30005749
[TBL] [Abstract][Full Text] [Related]
8. A cost effectiveness study of integrated care in health services delivery: a diabetes program in Australia.
McRae IS; Butler JR; Sibthorpe BM; Ruscoe W; Snow J; Rubiano D; Gardner KL
BMC Health Serv Res; 2008 Oct; 8():205. PubMed ID: 18834551
[TBL] [Abstract][Full Text] [Related]
9. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis.
Gillett M; Dallosso HM; Dixon S; Brennan A; Carey ME; Campbell MJ; Heller S; Khunti K; Skinner TC; Davies MJ
BMJ; 2010 Aug; 341():c4093. PubMed ID: 20729270
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Three Doses of a Behavioral Intervention to Prevent or Delay Type 2 Diabetes in Rural Areas.
Radcliff TA; Côté MJ; Whittington MD; Daniels MJ; Bobroff LB; Janicke DM; Perri MG
J Acad Nutr Diet; 2020 Jul; 120(7):1163-1171. PubMed ID: 31899170
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of general practice based, practice nurse led telephone coaching on glycaemic control of type 2 diabetes: the Patient Engagement and Coaching for Health (PEACH) pragmatic cluster randomised controlled trial.
Blackberry ID; Furler JS; Best JD; Chondros P; Vale M; Walker C; Dunning T; Segal L; Dunbar J; Audehm R; Liew D; Young D
BMJ; 2013 Sep; 347():f5272. PubMed ID: 24048296
[TBL] [Abstract][Full Text] [Related]
12. Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets.
Valentine WJ; Palmer AJ; Nicklasson L; Cobden D; Roze S
Int J Clin Pract; 2006 Sep; 60(9):1138-45. PubMed ID: 16939559
[TBL] [Abstract][Full Text] [Related]
13. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
14. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
Trials; 2013 Jul; 14():198. PubMed ID: 23829417
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa.
Huang SJ; Galárraga O; Smith KA; Fuimaono S; McGarvey ST
Hum Resour Health; 2019 Mar; 17(1):17. PubMed ID: 30836964
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.
Tao L; Wilson EC; Wareham NJ; Sandbaek A; Rutten GE; Lauritzen T; Khunti K; Davies MJ; Borch-Johnsen K; Griffin SJ; Simmons RK
Diabet Med; 2015 Jul; 32(7):907-19. PubMed ID: 25661661
[TBL] [Abstract][Full Text] [Related]
17. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
[TBL] [Abstract][Full Text] [Related]
18. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial.
Warren R; Carlisle K; Mihala G; Scuffham PA
J Telemed Telecare; 2018 Oct; 24(9):586-595. PubMed ID: 28814128
[TBL] [Abstract][Full Text] [Related]
19. Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes.
Palmer AJ; Roze S; Lammert M; Valentine WJ; Minshall ME; Nicklasson L; Gall MA; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S41-51. PubMed ID: 15324515
[TBL] [Abstract][Full Text] [Related]
20. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
Valentine WJ; Bottomley JM; Palmer AJ; Brändle M; Foos V; Williams R; Dormandy JA; Yates J; Tan MH; Massi-Benedetti M;
Diabet Med; 2007 Sep; 24(9):982-1002. PubMed ID: 17593245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
